Xeris Pharmaceuticals News and Activities

Presence

Xeris Pharmaceuticals develops and commercializes specialty medicines and drug delivery solutions. Its products focus on endocrine, neurology, and hospital care needs for patients, healthcare providers, and health systems.

Xeris Pharmaceuticals products and services overview:

Specialty medicines
Injectable therapies
Drug delivery
Endocrine treatments
Neurology treatments
Hospital care

Revenue: ~$204 million

Employees: 400

Headquarters: Chicago, United States (USA)

Xeris Pharmaceuticals is one of the...

Xeris Pharmaceuticals is a company listed under the stock ticker XERS (US).

Executives

View the org chart displaying its 34 main executives

Most searched biographies at Xeris Pharmaceuticals

Popular executive movements at Xeris Pharmaceuticals

John Shannon, who was Chief Executive Officer and Director, is promoted to Chief Executive Officer and Chairman of the Board (posted on July 2 2026).
Marla Persky, who was Independent Non-Executive Chairperson of the Board, is promoted to Lead Independent Director (posted on July 2 2026).
Nerissa Kreher has joined the company as Director (posted on July 2 2026).

Create your alert
to follow the executive moves at Xeris Pharmaceuticals.